chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Chronic obstructive pulmonary disease, Fatigue, Feeling hot, Gait inability, Insomnia
Clinical narrative: COPD; gait seems to be off when walking outside; Feling queasy; Tired; could not sleep; Felt warm; arm started to hurt three hours after the injection; This spontaneous case was reported by a consumer and describes the occurrence of CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), PAIN IN EXTREMITY (arm started to hurt three hours after the injection), INSOMNIA (could not sleep), GAIT INABILITY (gait seems to be off when walking outside) and FEELING HOT (Felt warm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm started to hurt three hours after the injection). On 27-Feb-2021, the patient experienced INSOMNIA (could not sleep), FEELING HOT (Felt warm) and FATIGUE (Tired). On 28-Feb-2021, the patient experienced GAIT INABILITY (gait seems to be off when walking outside) and NAUSEA (Feling queasy). On an unknown date, the patient experienced CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). The patient was treated with PARACETAMOL (TYLENOL) on 27-Feb-2021 for Adverse reaction, at a dose of 2 Tab. On 28-Feb-2021, PAIN IN EXTREMITY (arm started to hurt three hours after the injection), INSOMNIA (could not sleep), FEELING HOT (Felt warm) and FATIGUE (Tired) had resolved. At the time of the report, CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), GAIT INABILITY (gait seems to be off when walking outside) and NAUSEA (Feling queasy) outcome was unknown.            Patient's concomitant medication included Rescue inhaler  Patient's symptoms of feeling tired, could not sleep, felt warm abated after taking two Paracetamol.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity
Clinical narrative: COPD; gait seems to be off when walking outside; Feling queasy; Tired; could not sleep; Felt warm; arm started to hurt three hours after the injection; This spontaneous case was reported by a consumer and describes the occurrence of CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), PAIN IN EXTREMITY (arm started to hurt three hours after the injection), INSOMNIA (could not sleep), GAIT INABILITY (gait seems to be off when walking outside) and FEELING HOT (Felt warm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm started to hurt three hours after the injection). On 27-Feb-2021, the patient experienced INSOMNIA (could not sleep), FEELING HOT (Felt warm) and FATIGUE (Tired). On 28-Feb-2021, the patient experienced GAIT INABILITY (gait seems to be off when walking outside) and NAUSEA (Feling queasy). On an unknown date, the patient experienced CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). The patient was treated with PARACETAMOL (TYLENOL) on 27-Feb-2021 for Adverse reaction, at a dose of 2 Tab. On 28-Feb-2021, PAIN IN EXTREMITY (arm started to hurt three hours after the injection), INSOMNIA (could not sleep), FEELING HOT (Felt warm) and FATIGUE (Tired) had resolved. At the time of the report, CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), GAIT INABILITY (gait seems to be off when walking outside) and NAUSEA (Feling queasy) outcome was unknown.            Patient's concomitant medication included Rescue inhaler  Patient's symptoms of feeling tired, could not sleep, felt warm abated after taking two Paracetamol.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy, Pain in extremity, Vaccination site movement impairment
Clinical narrative: it is starting to swell under their armpit; arm has been extremely painful, they cannot move it, it has blew up, swollen up; sore arm; sore arm arm has been extremely painful; This spontaneous case was reported by an other health care professional and describes the occurrence of AXILLARY PAIN (sore arm arm has been extremely painful), LYMPHADENOPATHY (it is starting to swell under their armpit), VACCINATION SITE MOVEMENT IMPAIRMENT (arm has been extremely painful, they cannot move it, it has blew up, swollen up) and PAIN IN EXTREMITY (sore arm) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 030L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced AXILLARY PAIN (sore arm arm has been extremely painful). On an unknown date, the patient experienced LYMPHADENOPATHY (it is starting to swell under their armpit), VACCINATION SITE MOVEMENT IMPAIRMENT (arm has been extremely painful, they cannot move it, it has blew up, swollen up) and PAIN IN EXTREMITY (sore arm). At the time of the report, AXILLARY PAIN (sore arm arm has been extremely painful), LYMPHADENOPATHY (it is starting to swell under their armpit), VACCINATION SITE MOVEMENT IMPAIRMENT (arm has been extremely painful, they cannot move it, it has blew up, swollen up) and PAIN IN EXTREMITY (sore arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment included icing, pain medication and elevating the arm No concomitant medications reported by reporter.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Dry eye, Pain, Vaccination site mass, Visual impairment
Clinical narrative: Vision has tripled; Dry eyes; Knot at injection site; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of VISUAL IMPAIRMENT (Vision has tripled), DRY EYE (Dry eyes), VACCINATION SITE MASS (Knot at injection site) and PAIN (Body aches) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VISUAL IMPAIRMENT (Vision has tripled), DRY EYE (Dry eyes), VACCINATION SITE MASS (Knot at injection site) and PAIN (Body aches). At the time of the report, VISUAL IMPAIRMENT (Vision has tripled), DRY EYE (Dry eyes), VACCINATION SITE MASS (Knot at injection site) and PAIN (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  Treatment medications was not provided by the reporter
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: hot area around injection site; itchy area around injection site; Red area around injection site; swollen area around injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot area around injection site), VACCINATION SITE PRURITUS (itchy area around injection site), VACCINATION SITE ERYTHEMA (Red area around injection site) and VACCINATION SITE SWELLING (swollen area around injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014m2oa) for COVID-19 vaccination.     The medical history was not provided by the reporter.  Concomitant products included ALPHA LIPOIC ACID, GABAPENTIN, GLIMEPIRIDE, METFORMIN, METOPROLOL, ATORVASTATIN, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), COENZYME Q10 [UBIDECARENONE], VITAMIN D [VITAMIN D NOS] and VITAMIN B12 NOS for an unknown indication.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE WARMTH (hot area around injection site), VACCINATION SITE PRURITUS (itchy area around injection site), VACCINATION SITE ERYTHEMA (Red area around injection site) and VACCINATION SITE SWELLING (swollen area around injection site). At the time of the report, VACCINATION SITE WARMTH (hot area around injection site) and VACCINATION SITE SWELLING (swollen area around injection site) had not resolved and VACCINATION SITE PRURITUS (itchy area around injection site) and VACCINATION SITE ERYTHEMA (Red area around injection site) had resolved.            On 26-FEB-2021, patient had circular area about 3-4 inches in diameter around the injection site that was red, hot, swollen and itchy. The area got worse until 28-FEB-2021 when it started getting a little better. At the time of report, the area was still swollen and hot.  Patient applied Cold washcloth on the area as treatment.   This case was linked to MOD-2021-230147 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Follow up report included no new information
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: itches; redness at the injection site; soreness in the injection site/extreme pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itches), VACCINATION SITE PAIN (soreness in the injection site/extreme pain at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE PAIN (soreness in the injection site/extreme pain at the injection site). On 26-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itches) and VACCINATION SITE ERYTHEMA (redness at the injection site). At the time of the report, VACCINATION SITE PRURITUS (itches) outcome was unknown and VACCINATION SITE PAIN (soreness in the injection site/extreme pain at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  On 18-FEB-2021 patient had a little bit of soreness in the injection site but that was gone the following day. Eight days later on 26-FEB-2021, patient started to have extreme pain at the injection site.  Patient did not take any medications for the symptoms.
Sex: F
Vaccine: COVID19
Symptoms: Arthritis
Clinical narrative: This spontaneous case was reported by a patient and describes the occurrence of ARTHRITIS (bad arthritis flare up in her leg) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced ARTHRITIS (bad arthritis flare up in her leg). At the time of the report, ARTHRITIS (bad arthritis flare up in her leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment reported
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Chills, Cough, Polymerase chain reaction
Clinical narrative: Cough; chills; joint pain; Tested positive for Covid-19; This spontaneous case was reported by a nurse and describes the occurrence of   in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product DEXAMETHASONE for an unknown indication.    The patient's past medical history included No adverse event.   On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started DEXAMETHASONE (unknown route) 1 dosage form. The patient was treated with AZITHROMYCIN (ZITHROMAX) at a dose of 1 dosage form; PREDNISONE at a dose of 1 dosage form; DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. Unknown    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, Polymerase chain reaction: positive Positive.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: Urinary Tract Infection; A Spontaneous report was received from a consumer concerning a 90-years old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced urinary tract infection.     The patient's medical historywas not provided.. Concomitant medications use was not provided by the reporter.      On 27 JAN 2021, approximately 30 days  prior to the onset of the symptoms, the patient received her first of two planned doses of mRNA-1273 via unknown route for prophylaxis of COVID-19 infection.     On 25  Feb 2021, the patient experienced Urinary tract infection.  Treatment for urinary tract infection included antibiotics.    Action taken with mRNA-1273 in response to the event was not provided.   Outcome of the event urinary tract infection was not reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Mammogram, Paraesthesia, Ultrasound breast
Clinical narrative: tingling; swelling under the lymph nodes both arms; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling) and LYMPHADENOPATHY (swelling under the lymph nodes both arms) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jan-2021, the patient experienced PARAESTHESIA (tingling) and LYMPHADENOPATHY (swelling under the lymph nodes both arms). At the time of the report, PARAESTHESIA (tingling) and LYMPHADENOPATHY (swelling under the lymph nodes both arms) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, Mammogram: normal. On 18-Jan-2021, Ultrasound breast: normal.         This case was linked to MOD-2021-056421 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased, Vision blurred
Clinical narrative: blurred vision; blood sugar 611; This spontaneous case was reported by a nurse and describes the occurrence of VISION BLURRED (blurred vision) and BLOOD GLUCOSE INCREASED (blood sugar 611) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 026L2019) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus. Concomitant products included TELMISARTAN for Blood pressure, METFORMIN and BUSPIRONE HYDROCHLORIDE (BUSPAR) for an unknown indication.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VISION BLURRED (blurred vision) and BLOOD GLUCOSE INCREASED (blood sugar 611). At the time of the report, VISION BLURRED (blurred vision) and BLOOD GLUCOSE INCREASED (blood sugar 611) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable  no treatment information provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Chills, Dyspnoea, Heart rate, Hypertension
Clinical narrative: difficult breathing; high blood pressure; tachycardia; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (difficult breathing), HYPERTENSION (high blood pressure), TACHYCARDIA (tachycardia), CHILLS (chills) and PYREXIA (fever) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced DYSPNOEA (difficult breathing), HYPERTENSION (high blood pressure), TACHYCARDIA (tachycardia), CHILLS (chills) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, DYSPNOEA (difficult breathing), HYPERTENSION (high blood pressure), TACHYCARDIA (tachycardia), CHILLS (chills) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, Blood pressure measurement (80-120 mmHg): 171/117 mmHg (High) 171/117. On 01-Mar-2021, Heart rate: 110 (High) 110.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product was reported For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tachycardia
Clinical narrative: difficult breathing; high blood pressure; tachycardia; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (difficult breathing), HYPERTENSION (high blood pressure), TACHYCARDIA (tachycardia), CHILLS (chills) and PYREXIA (fever) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced DYSPNOEA (difficult breathing), HYPERTENSION (high blood pressure), TACHYCARDIA (tachycardia), CHILLS (chills) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, DYSPNOEA (difficult breathing), HYPERTENSION (high blood pressure), TACHYCARDIA (tachycardia), CHILLS (chills) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, Blood pressure measurement (80-120 mmHg): 171/117 mmHg (High) 171/117. On 01-Mar-2021, Heart rate: 110 (High) 110.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product was reported For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Nausea, Pyrexia
Clinical narrative: Chills; fever of 102°F until midnight that came down to 101; Later that afternoon started having temperature, and then a fever, and experienced nausea; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 102°F until midnight that came down to 101), NAUSEA (Later that afternoon started having temperature, and then a fever, and experienced nausea) and CHILLS (Chills) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 from 03-Jan-2021 to 15-Jan-2021.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PYREXIA (fever of 102°F until midnight that came down to 101) and NAUSEA (Later that afternoon started having temperature, and then a fever, and experienced nausea). On an unknown date, the patient experienced CHILLS (Chills). At the time of the report, PYREXIA (fever of 102°F until midnight that came down to 101), NAUSEA (Later that afternoon started having temperature, and then a fever, and experienced nausea) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, Body temperature: 102. On an unknown date, Body temperature: 101 midnight that came down to 101.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Eye colour change, Migraine
Clinical narrative: m Right eye and part of left eye was blinded by yellow color for about a minute.; Migraine headache; Right kneel hurting; This spontaneous case was reported by a consumer and describes the occurrence of EYE COLOUR CHANGE (m Right eye and part of left eye was blinded by yellow color for about a minute.), MIGRAINE (Migraine headache) and ARTHRALGIA (Right kneel hurting) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included Gout.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced ARTHRALGIA (Right kneel hurting). On 16-Feb-2021, the patient experienced EYE COLOUR CHANGE (m Right eye and part of left eye was blinded by yellow color for about a minute.) and MIGRAINE (Migraine headache). At the time of the report, EYE COLOUR CHANGE (m Right eye and part of left eye was blinded by yellow color for about a minute.), MIGRAINE (Migraine headache) and ARTHRALGIA (Right kneel hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Headache, Injection site warmth, Pain in extremity
Clinical narrative: Hot to touch; Redness; Swelling; Rash the size of a bullseye; Soreness in arm; Headache; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Hot to touch), ERYTHEMA (Redness), PAIN IN EXTREMITY (Soreness in arm), SWELLING (Swelling) and RASH (Rash the size of a bullseye) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032220A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No historical condition was reported).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced HEADACHE (Headache) and FATIGUE (Tiredness). On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (Soreness in arm). On 05-Feb-2021, the patient experienced ERYTHEMA (Redness), SWELLING (Swelling) and RASH (Rash the size of a bullseye). On 08-Feb-2021, the patient experienced INJECTION SITE WARMTH (Hot to touch). On 31-Jan-2021, HEADACHE (Headache) and FATIGUE (Tiredness) had resolved. On 07-Feb-2021, ERYTHEMA (Redness) outcome was unknown, SWELLING (Swelling) and RASH (Rash the size of a bullseye) had resolved. At the time of the report, INJECTION SITE WARMTH (Hot to touch) and PAIN IN EXTREMITY (Soreness in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants or treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-090348, US-MODERNATX, INC.-MOD-2021-090495, US-MODERNATX, INC.-MOD-2021-090656 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-090495: US-MODERNATX, INC.-MOD-2021-090348:Crosslinked Case
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Swelling
Clinical narrative: Hot to touch; Redness; Swelling; Rash the size of a bullseye; Soreness in arm; Headache; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Hot to touch), ERYTHEMA (Redness), PAIN IN EXTREMITY (Soreness in arm), SWELLING (Swelling) and RASH (Rash the size of a bullseye) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032220A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No historical condition was reported).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced HEADACHE (Headache) and FATIGUE (Tiredness). On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (Soreness in arm). On 05-Feb-2021, the patient experienced ERYTHEMA (Redness), SWELLING (Swelling) and RASH (Rash the size of a bullseye). On 08-Feb-2021, the patient experienced INJECTION SITE WARMTH (Hot to touch). On 31-Jan-2021, HEADACHE (Headache) and FATIGUE (Tiredness) had resolved. On 07-Feb-2021, ERYTHEMA (Redness) outcome was unknown, SWELLING (Swelling) and RASH (Rash the size of a bullseye) had resolved. At the time of the report, INJECTION SITE WARMTH (Hot to touch) and PAIN IN EXTREMITY (Soreness in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants or treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-090348, US-MODERNATX, INC.-MOD-2021-090495, US-MODERNATX, INC.-MOD-2021-090656 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-090495: US-MODERNATX, INC.-MOD-2021-090348:Crosslinked Case
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history was reported). Concomitant products included LEVOTHYROXINE SODIUM (TIROSINT), LEVOTHYROXINE and BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea). At the time of the report, DIARRHOEA (diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Hypokinesia, Vaccination site pain
Clinical narrative: Unable to lift arm; Arm hurts/it is painful; This spontaneous case was reported by a consumer and describes the occurrence of HYPOKINESIA (Unable to lift arm) and VACCINATION SITE PAIN (Arm hurts/it is painful) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced HYPOKINESIA (Unable to lift arm) and VACCINATION SITE PAIN (Arm hurts/it is painful). At the time of the report, HYPOKINESIA (Unable to lift arm) and VACCINATION SITE PAIN (Arm hurts/it is painful) outcome was unknown. Not Provided          No relevant concomitant medications were reported. No treatment information was reported. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: got tested positive for covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (got tested positive for covid) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K202-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced COVID-19 (got tested positive for covid). The patient was treated with VITAMIN D NOS ongoing since an unknown date for COVID-19, at an unspecified dose and frequency; GUAIFENESIN (MUCINEX) ongoing since an unknown date for COVID-19, at an unspecified dose and frequency; DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) ongoing since an unknown date for COVID-19, at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (got tested positive for covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, SARS-CoV-2 test positive: (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Developed shingles; This spontaneous case was reported by a health care professional and describes the occurrence of HERPES ZOSTER (Developed shingles) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Developed shingles). At the time of the report, HERPES ZOSTER (Developed shingles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant details were not reported by the reporter. Treatment included steroids and antivirals.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vomiting
Clinical narrative: Dizzy; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy) and VOMITING (Vomiting) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was not reported by the reporter.  Concomitant products included ONDANSETRON (ZOFRAN [ONDANSETRON]) for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced DIZZINESS (Dizzy) and VOMITING (Vomiting). At the time of the report, DIZZINESS (Dizzy) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details was not reported by the reporter.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Itchy injection site; Sore injection site; Red injection site; Swollen injection site; Hot injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot injection site), VACCINATION SITE PRURITUS (Itchy injection site), VACCINATION SITE PAIN (Sore injection site), VACCINATION SITE ERYTHEMA (Red injection site) and VACCINATION SITE SWELLING (Swollen injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot injection site), VACCINATION SITE PAIN (Sore injection site), VACCINATION SITE ERYTHEMA (Red injection site) and VACCINATION SITE SWELLING (Swollen injection site). On 17-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy injection site). At the time of the report, VACCINATION SITE WARMTH (Hot injection site), VACCINATION SITE PRURITUS (Itchy injection site), VACCINATION SITE PAIN (Sore injection site), VACCINATION SITE ERYTHEMA (Red injection site) and VACCINATION SITE SWELLING (Swollen injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included antihistamine and steroid ointment.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Muscle spasms, Pyrexia
Clinical narrative: Leg cramping; Fever 100.0; Felt weak; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Leg cramping), PYREXIA (Fever 100.0) and ASTHENIA (Felt weak) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced MUSCLE SPASMS (Leg cramping), PYREXIA (Fever 100.0) and ASTHENIA (Felt weak). The patient was treated with CODEINE PHOSPHATE, PARACETAMOL (TYLENOL WITH CODEINE) at an unspecified dose and frequency. At the time of the report, MUSCLE SPASMS (Leg cramping), PYREXIA (Fever 100.0) and ASTHENIA (Felt weak) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Feb-2021, Body temperature: 100 (Inconclusive) 100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient drank pickle juice and Gatorade. No relevant concomitant medications were reported. Action taken with mRNA-1273 in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Disorientation
Clinical narrative: Weakness; Disorientation; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness) and DISORIENTATION (Disorientation) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced ASTHENIA (Weakness) and DISORIENTATION (Disorientation). At the time of the report, ASTHENIA (Weakness) and DISORIENTATION (Disorientation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Side effects after receiving the second dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects after receiving the second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION COMPLICATION (Side effects after receiving the second dose). At the time of the report, VACCINATION COMPLICATION (Side effects after receiving the second dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: reactions from 1st dose of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (reactions from 1st dose of the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (reactions from 1st dose of the vaccine). At the time of the report, VACCINATION COMPLICATION (reactions from 1st dose of the vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication were not reported by the reporter. Treatment details was not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: arm was sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm was sore at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PAIN (arm was sore at the injection site). At the time of the report, VACCINATION SITE PAIN (arm was sore at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pain, Pyrexia
Clinical narrative: Pain; Fever of 102 F; Achiness; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 102 F), PAIN (Achiness) and PAIN (Pain) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced PYREXIA (Fever of 102 F) and PAIN (Achiness). On 14-Feb-2021, the patient experienced PAIN (Pain). On 14-Feb-2021, PYREXIA (Fever of 102 F) had resolved. On 15-Feb-2021, PAIN (Achiness) and PAIN (Pain) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) 102F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Nausea
Clinical narrative: little bit of diarrhea; chill; little bit of nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (little bit of diarrhea), CHILLS (chill) and NAUSEA (little bit of nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (little bit of diarrhea), CHILLS (chill) and NAUSEA (little bit of nausea). At the time of the report, DIARRHOEA (little bit of diarrhea), CHILLS (chill) and NAUSEA (little bit of nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discomfort, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: injection site is more sensitive; red; swollen; discomfort in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (discomfort in the injection site), VACCINATION SITE PAIN (injection site is more sensitive), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE SWELLING (swollen) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE DISCOMFORT (discomfort in the injection site). On 11-Feb-2021, the patient experienced VACCINATION SITE PAIN (injection site is more sensitive), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE SWELLING (swollen). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE DISCOMFORT (discomfort in the injection site), VACCINATION SITE PAIN (injection site is more sensitive), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE SWELLING (swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant details were not reported by the reporter. Treatment included also ice.   Reporter did not allow further contact
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site pain, Vaccination site rash
Clinical narrative: Rash under her bosom; Tender injection site, Sore injection site; Rash in injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash under her bosom), VACCINATION SITE PAIN (Tender injection site, Sore injection site) and VACCINATION SITE RASH (Rash in injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced RASH (Rash under her bosom), VACCINATION SITE PAIN (Tender injection site, Sore injection site) and VACCINATION SITE RASH (Rash in injection site). At the time of the report, RASH (Rash under her bosom), VACCINATION SITE PAIN (Tender injection site, Sore injection site) and VACCINATION SITE RASH (Rash in injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Gout
Clinical narrative: gout; This spontaneous case was reported by a consumer and describes the occurrence of GOUT (gout) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced GOUT (gout). At the time of the report, GOUT (gout) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Eye pruritus, Nervousness, Rash erythematous, Vaccination site rash
Clinical narrative: Anxious; Nervous; Itchy eyes; large rash at the site of the injection measuring 3 by 6 inches in length; red (rash); This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxious), NERVOUSNESS (Nervous), EYE PRURITUS (Itchy eyes), VACCINATION SITE RASH (large rash at the site of the injection measuring 3 by 6 inches in length) and RASH ERYTHEMATOUS (red (rash)) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included Anaphylactic shock.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE RASH (large rash at the site of the injection measuring 3 by 6 inches in length) and RASH ERYTHEMATOUS (red (rash)). On an unknown date, the patient experienced ANXIETY (Anxious), NERVOUSNESS (Nervous) and EYE PRURITUS (Itchy eyes). At the time of the report, ANXIETY (Anxious), NERVOUSNESS (Nervous), EYE PRURITUS (Itchy eyes), VACCINATION SITE RASH (large rash at the site of the injection measuring 3 by 6 inches in length) and RASH ERYTHEMATOUS (red (rash)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.